AlphaStocks
5.3
Consider Buy

Humana Inc (HUM)

As of Sep 20, 2026, Humana Inc (HUM) scores 5.3/10 on AlphaStocks' five-model composite, #84 of 168 Health Care stocks. At $386, HUM trades 20% above its model fair value of $322.

Health Care / Managed Health Care

S&P 500

$385.96

Below average on several measures. Research carefully.

Consider Buy

Score based on 5 of 5 models — high confidence

Data as of Sep 20, 2026

#84out of 168 in Health Care

Is HUMANA INC a Good Investment in 2026?

HUMANA INC (HUM) scores 5.3 out of 10 on AlphaStocks' composite model, earning a Consider Buy rating. The Piotroski model rates HUMANA INC as Attractive (6/9). However, the Buffett model rates it Caution. HUMANA INC currently trades 20% above its estimated fair value of $322. HUMANA INC ranks #84 out of 168 stocks in the Health Care sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

P/E39.3ROE6.6Market Cap47BDiv Yield0.9

Estimated Fair Value

$322.0220% above

Trading above estimated fair value. P/e of 39x implies high growth expectations. eps growth of -2% may not justify the premium.

Model-based estimate, not a price target.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Attractive

6/9

Buffett

Caution

Business quality & competitive moat

Graham

Neutral

Significantly above fair value

Lynch

Neutral

High PEG — growth premium · Stalwart

Greenblatt

Neutral

Earnings yield 4.9% · ROC 15%

Frequently Asked Questions

Is HUMANA INC (HUM) a good investment?
As of Sep 20, 2026, Humana Inc (HUM) scores 5.3/10 on AlphaStocks' five-model composite, #84 of 168 Health Care stocks. At $386, HUM trades 20% above its model fair value of $322. That score is below average, suggesting caution.
What is HUMANA INC's Piotroski F-Score?
HUMANA INC's Piotroski F-Score status is Attractive. The raw score is 6/9. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is HUM overvalued or undervalued?
Based on AlphaStocks' model-based fair value estimate of $322, HUM appears overvalued. The stock currently trades 20% above its estimated fair value. Trading above estimated fair value. P/e of 39x implies high growth expectations. eps growth of -2% may not justify the premium.
How does HUM compare to other Health Care stocks?
HUMANA INC ranks #84 out of 168 stocks in the Health Care sector, placing it in the top 50% of its sector by composite score. This is an above-average position relative to sector peers.
What do investment models say about HUM?
AlphaStocks evaluates HUM using five proven investment models. Piotroski: Attractive; Buffett: Caution; Graham: Neutral; Lynch: Neutral; Greenblatt Magic Formula: Neutral. These models are combined into a single composite score of 5.3/10.

Similar Stocks

MOHHQYELV

Compare HUM with

HUM vs MOHHQY vs HUMELV vs HUM

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer